NBER WORKING PAPER SERIES

DISPARITIES IN VULNERABILITY TO SEVERE COMPLICATIONS FROM COVID-19
IN THE UNITED STATES
Emily E. Wiemers
Scott Abrahams
Marwa AlFakhri
V. Joseph Hotz
Robert F. Schoeni
Judith A. Seltzer
Working Paper 27294
http://www.nber.org/papers/w27294

NATIONAL BUREAU OF ECONOMIC RESEARCH
1050 Massachusetts Avenue
Cambridge, MA 02138
June 2020

This paper was prepared with support, in part, from the Aging Studies In-stitute at Syracuse
University, the Duke Center for Population Health and Aging, which receives core support
(P30AG034424) from the National Institute on Aging, and by the California Center for Population Research at the University of California at Los Angeles, which receives core support (P2CHD041022) from the Eunice Kennedy Shriver National Institute of Child Health and Human
Development. The collection of data used in this study was partly supported by the National
Institutes of Health under grant number R01 HD069609 and R01 AG040213, and the National
Science Foundation under award numbers SES 1157698 and 1623684. The views expressed
herein are those of the authors and do not necessarily reflect the views of the National Bureau of
Economic Research.
NBER working papers are circulated for discussion and comment purposes. They have not been peerreviewed or been subject to the review by the NBER Board of Directors that accompanies official
NBER publications.
Â© 2020 by Emily E. Wiemers, Scott Abrahams, Marwa AlFakhri, V. Joseph Hotz, Robert F. Schoeni,
and Judith A. Seltzer. All rights reserved. Short sections of text, not to exceed two paragraphs, may
be quoted without explicit permission provided that full credit, including Â© notice, is given to the source.

Disparities in Vulnerability to Severe Complications from COVID-19 in the United States
Emily E. Wiemers, Scott Abrahams, Marwa AlFakhri, V. Joseph Hotz, Robert F. Schoeni,
and Judith A. Seltzer
NBER Working Paper No. 27294
June 2020
JEL No. I1,I14,I24,J1,J11,J14
ABSTRACT
This paper provides the first nationally representative estimates of vulnerability to severe complications from COVID-19 overall and across race-ethnicity and socioeconomic status. We use
the Panel Study of Income Dynamics (PSID) to examine the prevalence of specific health conditions associated with complications from COVID-19 and to calculate, for each individual, an
index of the risk of severe complications from respiratory infections developed by DeCaprio et al.
(2020). We show large disparities across race-ethnicity and socioeconomic status in the prevalence of conditions which are associated with the risk of severe complications from COVID-19.
Moreover, we show that these disparities emerge early in life, prior to age 65, leading to higher
vulnerability to such complications. While vulnerability is highest among older adults regardless
of their race-ethnicity or socioeconomic status, our results suggest particular attention should also
be given to the risk of adverse outcomes in midlife for non-Hispanic Blacks, adults with a high
school degree or less, and low-income Americans.
Emily E. Wiemers
Department of Public Administration
and International Affairs
Syracuse University
Syracuse, NY 13244
eewiemer@syr.edu
Scott Abrahams
Duke University
Department of Economics
419 Chapel Drive
213 Social Sciences Bldg.
Durham, NC 27708
scott.abrahams@duke.edu
Marwa AlFakhri
Duke University
Sanford School of Public Policy
201 Science Dr
Durham, NC 27708
m.alfakhri@duke.edu

V. Joseph Hotz
Department of Economics
Box 90097
Duke University
Durham, NC 27708-0097
and NBER
v.joseph.hotz@duke.edu
Robert F. Schoeni
Institute for Social Research
University of Michigan
426 Thompson St.
Ann Arbor, MI 48109
bschoeni@umich.edu
Judith A. Seltzer
Department of Sociology
University of California, Los Angeles
Los Angeles, CA 90095
seltzerj@ucla.edu

The presence of preexisting health conditions increases vulnerability to severe complications from COVID-19 (1). The CDC reports that over 90% of hospitalized patients have at least
one preexisting health condition (2). In hospitals in New York City, Long Island, and Westchester
County, NY, 94% of patients hospitalized had at least one preexisting condition, 88% had more
than one, and the median number was four (3). The most common conditions among patients hospitalized for COVID-19 are hypertension (3-13), diabetes, cardiovascular disease, kidney disease,
and obesity (3, 6-12). Conditional on hospitalization, those with preexisting conditions suffer more
severe outcomes (1, 6, 10-12) and experience higher fatality rates in China and the United States
(1, 11, 14).
In the United States, vulnerability to COVID-19 based on preexisting health conditions,
collides with long-standing disparities in health and mortality by race-ethnicity and socioeconomic
status, especially in midlife (15-17). Recent studies have highlighted these disparities finding that
Blacks, and the socioeconomically disadvantaged are more likely to have at least one health condition that makes them vulnerable to COVID-19 (18, 19). Indeed, COVID-19 hospitalization rates
are higher for Blacks, and Hispanics while Whites are underrepresented relative to their population
percentages (20, 21). Differences in mortality rates by race-ethnicity are staggering: in Washington
D.C., African Americans make up 45% of the population yet suffer 76% of deaths (22). Yet what
is lacking is a means of translating the well-known disparities in a multiplicity of health conditions
into predictions about how the likelihood of having serious complications from COVID-19 varies
across race-ethnicity and socioeconomic status. As the pandemic continues, the inability to translate health disparities into vulnerability to COVID-19 hampers our ability to be forward-looking
about differential impact of the virus.
This paper leverages a recent machine learning model of the likelihood of hospitalization
for several respiratory conditions (23). We apply the model to preexisting health conditions reported in the Panel Study of Income Dynamics (PSID) which allows us to form the first populationrepresentative estimates of vulnerability to in-patient hospitalization for respiratory conditions for
the U.S. and how vulnerability varies by education, income, and race-ethnicity. As the vulnerability index is itself a function of preexisting health conditions, we also examine the distribution of
such conditions across demographic groups.
We find that disparities in preexisting health conditions across race-ethnicity and socioeconomic status translate into large gaps in vulnerability. Adults with a high school education or less

1

are 1.6 times as likely as those with a college degree to face severe complications and Americans
in the lowest income quartile face 2.7 times the risk compared to those in the highest quartile.
These gaps are due to preexisting health conditions that emerge earlier in life for less-educated and
low-income adults. We also find large gaps in vulnerability appearing in midlife for non-Hispanic
Blacks, whereas Hispanics face lower risks based on preexisting health conditions and age. We
show that to understand disparities in vulnerability to severe complications from COVID-19, it is
crucial to describe how disparities in the age pattern of specific preexisting conditions and the
presence of multiple conditions would account for disparities in the incidence of severe complications from the COVID-19 pandemic in the U.S.
We also show that while disparities in preexisting health do predict disparities in complications from COVID-19, our predictions do not fully track the disparities in observed hospitalization from the virus. The differences in our predictions and actual hospitalizations suggests that
there are differences by race-ethnicity and socioeconomic status in exposure to the coronavirus,
the likelihood of infection given exposure, and in the complications from infections that go beyond
the disparities in preexisting health. Disparities in exposure based on residential and occupational
characteristics have been documented during the COVID-19 pandemic (6, 7). The persistence of
race-ethnic differences in hospitalization rates for COVID-19 after controlling for comorbidities
suggests there may be disparities in timely access to care (24). However, understanding variation
in vulnerability based on preexisting health conditions is crucial for predicting the likely disparities
in the effect of the disease and for assessing the role of factors beyond health conditions. For these
tasks, population-representative estimates are essential. While we focus on disparities in preexisting health conditions and their implications for vulnerability to severe complications, our work is
a complement to studies of disparities in exposure to the coronavirus (25-27) and in inequities in
health care (24, 28, 29).
MATERIALS AND METHODS
In this section we discuss the data and methods used to analyze the preexisting health conditions that the CDC and the developing literature indicate are risk factors for severe illness from
COVID-19. We begin with a discussion of the Panel Study of Income Dynamics (PSID) data that
we use to determine the distribution of and disparities in risk factors in the adult U.S. population.
We also describe the index of relative vulnerability to severe illness from respiratory infections

2

developed by ClosedLoop.ai (23), which is a function of preexisting conditions, recent hospitalization, and age. We discuss the construction of the index and how we apply it to nationally representative data.
Panel Study of Income Dynamics
The PSID is a national longitudinal survey that has interviewed the original sample members and their descendants since 1968. The original sample included oversamples of Black and
low-income families to facilitate the study of poverty. With the addition in 1997 of a sample of
immigrants who arrived in the United States after 1968 plus the addition in 2017 of a sample of
immigrants who arrived after 1997, the 2017 wave includes 26,455 individuals representative of
the national population when weighted (30). We use the 2017 data on adults ages 25 and older, a
sample of 13,150 household heads and spouses (or cohabiting partners) 1 who are not missing data
on age, race-ethnicity, educational attainment, household income, or preexisting health conditions. 2 Throughout our analyses, we apply the 2017 PSID cross-sectional weights.
Demographics and Socioeconomic Status
Race-ethnicity is classified as Hispanic, non-Hispanic Black, non-Hispanic White, and
non-Hispanic other. Because of sample size we do not report separate estimates for individuals
who are non-Hispanic other race. Education is categorized as no more than 12 years (high
school/GED or less), 13-15 years (some college), and at least 16 years (BA degree or more). Income is measured at the household level. We classify each adult according to the income quartile
of their household. 3
The population characteristics of our sample are displayed in Table 1. We show the distributions of gender, race-ethnicity, educational attainment, and household income quartile overall
and for three age groups (25-44, 45-64 and 65+). We also show the distribution of age across each
race-ethnic, educational attainment, and household income category. In Appendix A, we compare
1

PSID defines a cohabiting partner is one who has lived with the head for one year or more. Since 2017, the PSID has
referred to heads as â€œreference person 1â€ and spouses and cohabiters as â€œreference person 2.â€ For ease in comparison
to past work, we continue to use â€œheadâ€ and â€œspouse.â€

2

There are 13,831 heads and spouses age 25 and older. We dropped 681 due to missing data, 302 due to missing data
on race-ethnicity, education, or income and a further 379 due to missing data about health conditions, producing a
sample of 13,150.
3

The lowest quartile consisted of those households with reported incomes between $0 and $29,096; the second quartile, $29,096 and $56,760; the third quartile, $56,760 and $101,820; and the top quartile, incomes greater than
$101,820. The measure is based on reports about the income received in 2016 and is reported in 2016 dollars.

3

the PSID data to that of the Current Population Survey (CPS) from the 2017 Annual Social and
Economic Supplement (ASEC). Overall, the samples produce almost identical distributions. 4 Prior
work has shown that estimates of income from the PSID match well with those from the March
CPS (31).
Differences in the age distribution across demographic and socioeconomic groups matter
because the risks from COVID-19 vary with age. Females are one year older, which is consistent
with well-documented higher mortality rates for men. Non-Hispanic Whites (NH White) make up
71% of the adult U.S. population, while 11% are Non-Hispanic Blacks (NH Blacks), 13% are
Hispanics and 5% are other non-Hispanic groups. NH Whites are the oldest on average (53.6 years
old), followed by NH Blacks (49.2), and Hispanics are the youngest at 46.5 years. Among NH
Whites, 28% are 65 and older compared to only 17% of NH Blacks, and 13% of Hispanics. With
respect to educational attainment, 38% of people have a high school degree or less, 24% have
completed some college, and 38% have a BA degree or higher. Due to educational differences
across birth cohorts, those with a high school degree or less are older (54.3 years old) than those
with some college (51.2) or those with a BA (50.1). Finally, 18% of individuals in the adult population are in the lowest quartile of household income, while 23%, 28% and 32% are in the second,
third and top quartiles, respectively. Again, we see age differences across these quartiles, with
those in the lowest quartile being older (56.6 years) compared to the top two quartiles, which
average 50.4 years.
Self-Reported Health Conditions (Risk Factors)
The PSID includes questions about whether a person was ever told by a health professional
they have certain health conditions. Many of these conditions are listed by the CDC as risk factors
for becoming severely ill from infection of COVID-19. The health conditions (risk factors) in the
PSID include asthma, diabetes, heart disease, heart attack, hypertension, lung disease, neurological
conditions, cancer, stroke, and kidney disease. In addition, the PSID asks respondents whether
they were hospitalized in the previous year. Past hospitalization is a risk factor in the DeCaprio et
al. model described below. Finally, height and weight are reported, which we use to compute each

4
There are slight differences between the PSID and CPS samples for the distributions of educational attainment,
presumably because of slightly different questions and their wording.

4

respondentâ€™s BMI. We then create an indicator for severe obesity (BMI â‰¥ 40). Appendix B describes how estimates of the prevalence of self-reported health conditions in the PSID compare to
those in other data sources. Appendix Table B-1 shows the question wording for all self-reported
health conditions in the PSID.
Relative Vulnerability Index
According to the CDC, the risk of severe complications from COVID-19 resulting in hospitalization increases with a number of preexisting health conditions, i.e., risk factors or comorbidities, and with age, but the size of the effect of each risk factor is currently unknown (2). To
circumvent the lack of current data on these effects, DeCaprio et al. (23) assessed the risk of hospitalization for respiratory infections available in existing medical claims data. In particular, they
looked at (in-patient) hospitalizations associated with: acute respiratory distress syndrome, pneumonia (other than caused by tuberculosis), influenza, acute bronchitis and other upper respiratory
infections. DeCaprio et al. used medical claims data on hospitalizations for Medicare recipients â€“
using the Center for Medicare and Medicaid Services Limited Data Set, which contains a 5% sample of the Medicare population â€“ and from Healthfirst, a New York, non-Medicare population
insurer. They mapped in-patient hospitalizations from these respiratory infections to individuallevel data on 11 preexisting health conditions (risk factors) coded in the Medicare and Healthfirst
data, along with patientsâ€™ gender, age and whether they had been hospitalized in the last three
months.
As described in DeCaprio et al. (23), the authors estimated several alternative versions of
their model. In our paper, we use their â€œSurvey Model,â€ which is based on a logistic regression of
incidence of hospitalizations due to the above conditions and is suitable for use with the health
conditions available in the PSID. 5 The model is trained on over 2 million individuals.
The model is of the following form. Let ğ‘‘ğ‘‘ğ‘–ğ‘– denote a 0/1 indicator of whether individual i

is hospitalized with a severe respiratory infection. Then,
(1)

ğ‘ğ‘ğ‘–ğ‘– â‰¡ ğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒ(ğ‘‘ğ‘‘ğ‘–ğ‘– = 1) = exp(ğ‘‰ğ‘‰ğ‘‰ğ‘‰ğ‘–ğ‘–âˆ— )â„[1 + exp(ğ‘‰ğ‘‰ğ‘‰ğ‘‰ğ‘–ğ‘–âˆ— )],

where ğ‘‘ğ‘‘ğ‘–ğ‘– is a 0/1 indicator for whether i is hospitalized and ğ‘‰ğ‘‰ğ‘‰ğ‘‰ğ‘–ğ‘– denotes individual iâ€™s Vulnerability

Index score which is given by the following function:

5

At https://closedloop.ai/c19index/ one can calculate values of what they refer to as the â€œC-19indexâ€ based on risk
factors, hospitalization experience and age. The Survey Model that we use is similar, but not exactly the same, as the
web model is trained on additional information that we do not use, e.g., zip-code.

5

ğ‘‰ğ‘‰ğ‘‰ğ‘‰ğ‘–ğ‘–âˆ— = ğ›½ğ›½0 + ğ›½ğ›½1 ğ´ğ´ğ´ğ´ğ´ğ´ğ‘–ğ‘– + ğ›½ğ›½2 ğ‘€ğ‘€ğ‘€ğ‘€ğ‘€ğ‘€ğ‘€ğ‘€ğ‘–ğ‘– + ğ›½ğ›½3 ğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘–ğ‘– + ğœ·ğœ·4 ğ‘¹ğ‘¹ğ‘–ğ‘– + ğœ·ğœ·5 ğ‘¹ğ‘¹ğ‘–ğ‘– âˆ™ ğ´ğ´ğ´ğ´ğ´ğ´ğ‘–ğ‘– ,

(2)

where ğ´ğ´ğ´ğ´ğ´ğ´ğ‘–ğ‘– is iâ€™s current age, ğ‘€ğ‘€ğ‘€ğ‘€ğ‘€ğ‘€ğ‘€ğ‘€ğ‘–ğ‘– is a 0/1 indicator of whether i is a male; ğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘–ğ‘– is a 0/1
indicator of whether i has been recently hospitalized, and ğ‘¹ğ‘¹ğ‘–ğ‘– is a vector of 0/1 indicators for

whether i has particular health conditions, or risk factors, ğ‘…ğ‘…ğ‘˜ğ‘˜ğ‘˜ğ‘˜ k, k = 1,â€¦, K. Given the logistic
form of (1), it follows that ğ‘‰ğ‘‰ğ‘‰ğ‘‰ğ‘–ğ‘–âˆ— is the log odds of severe illness for individual i that is a function of
their age, gender, recent hospitalization and health-related risk factors. It follows that
ï¿½ğš¤ğš¤ = exp(ğ‘‰ğ‘‰ğ‘‰ğ‘‰ğ‘–ğ‘–âˆ— )
ğ‘‰ğ‘‰ğ‘‰ğ‘‰

(3)

is their odds ratio of risk for a severe illness or the relative vulnerability index score for individual
i.
Given the expression for ğ‘‰ğ‘‰ğ‘‰ğ‘‰ğ‘–ğ‘–âˆ— in (2), the base group for the DeCaprio et al. model is a female

with no preexisting risk factors and age equal to 0. But, to provide a more meaningful base group,
we use the following relative vulnerability index score:
ğ‘‰ğ‘‰ğ‘‰ğ‘‰ğ‘–ğ‘– = exp(ğ‘‰ğ‘‰ğ‘‰ğ‘‰ğ‘–ğ‘–âˆ— âˆ’ ğ›½ğ›½0 âˆ’ ğ›½ğ›½1 âˆ™ 30)

(4)

so ğ‘‰ğ‘‰ğ‘‰ğ‘‰ğ‘–ğ‘– provides the odds that individual i has of a severe illness relative to that for a 30-year-old

female with no risk factors. We report average ğ‘‰ğ‘‰ğ‘‰ğ‘‰ğ‘–ğ‘– by age, race-ethnicity, education, and household
income.

In Appendix Table B-2, we display, in the first two columns, respectively, the risk factors
in ğ‘¹ğ‘¹ğ‘–ğ‘– for the DeCaprio et al. model and estimates of the ğ›½ğ›½ğ‘—ğ‘— â€™s for ğ‘‰ğ‘‰ğ‘‰ğ‘‰ğ‘–ğ‘–âˆ— in (2). The third column in

Appendix Table B-1 indicates which health risk factors are available in the PSID. As one can see,

the PSID does not measure some risk factors included in the DeCaprio et al. model. In our implementation of the vulnerability index with PSID data, we do not attempt to adjust the formula for
absent variables; rather, we act as if the members of the PSID sample do not have these conditions.
Because of this, the values of the vulnerability index scores for our sample will be biased downwards. As discussed in Appendix B, almost all of the risk factors used in the DeCaprio et al. model
that are not available in the PSID, with the exception of liver disease (cirrhosis of the liver), either
have very low marginal impacts on the vulnerability index (based on the coefficient estimates for
these conditions) or the incidence of the risk factor is very low in the U.S. population.
Finally, to demonstrate how the various risk factors affect the relative vulnerability index
scores, we present, in Figure 1, the age profiles of the marginal contributions of each risk factor to
relative vulnerability. The marginal contribution at age, ğ´ğ´ğ´ğ´ğ´ğ´ğ‘–ğ‘– , for risk factor, ğ‘…ğ‘…ğ‘˜ğ‘˜ğ‘–ğ‘– , is given by:

6

ğœ•ğœ•ğ‘‰ğ‘‰ğ‘‰ğ‘‰ğ‘–ğ‘–

(5)

ğ‘…ğ‘…ğ‘˜ğ‘˜ğ‘˜ğ‘˜

= (ğ›½ğ›½4ğ‘˜ğ‘˜ + ğ›½ğ›½5ğ‘˜ğ‘˜ ğ´ğ´ğ´ğ´ğ´ğ´ğ‘–ğ‘– ) âˆ™ exp(ğ›½ğ›½1 [ğ´ğ´ğ´ğ´ğ´ğ´ğ‘–ğ‘– âˆ’ 30] + ğ›½ğ›½4ğ‘˜ğ‘˜ + ğ›½ğ›½5ğ‘˜ğ‘˜ ğ´ğ´ğ´ğ´ğ´ğ´ğ‘–ğ‘– ),

where we evaluate all of the other risk factors, ğ‘…ğ‘…ğ‘šğ‘šğ‘šğ‘š , ğ‘šğ‘š â‰  ğ‘˜ğ‘˜, at 0.

In Figure 1, we draw attention to those risk factors that have the most sizeable contributions

to vulnerability at various ages by labeling them in the figure. As one can see from Figure 1,
hypertension and lung disease have the largest impacts on the relative vulnerability index at all
ages, and both effects rise rapidly with age. Severe obesity â€“ and, to a lesser extent, cancer â€“ also
consistently have a large impact on the vulnerability index at all ages. In early adulthood (25-44),
asthma contributes a sizeable impact on relative vulnerability, but this risk factor is less important
at midlife (45-64) and older ages (65+). With age, one also sees that heart disease and heart attacks
contribute to relative vulnerability. At older ages (65+), neurological conditions start to have substantial impacts on relative vulnerability. Finally, recent hospitalizations, which presumably proxy
for compromised health, have larger impacts on relative vulnerability as individuals age.
All of the other risk factors have more modest impacts, raising the vulnerability odds of
severe disease relative to a 30-year old female with no risk factors 2 to 5 times and do not vary
substantially with age. Nonetheless, the DeCaprio et al. model implies that the increase in relative
vulnerability to severe illness will result, in large part, from the number of conditions one has at
any age.
Three final points about Figure 1. First, age, per se, has a very small impact on relative
vulnerability. That is, growing older, when one has no risk factors, has virtually no impact on
vulnerability. It is the accumulation of risk factors and the interactions of these risk factors with
age that lead to higher vulnerability at older ages. Second, a male, who has no other health-related
risk factors, is at slightly higher vulnerability to severe illness compared to females and this malefemale differential in vulnerability rises modestly with age, so that, by age 72, a maleâ€™s vulnerability, relative to a 30-year old female, is 1.14 times higher. Third, the distribution of and disparities
in the relative vulnerability to severe illness from COVID-19 in the U.S. adult population reported
below will be driven by the marginal contributions of individual risk factors displayed in Figure 1
based on the DeCaprio et al. model and by the prevalence of these risk factors in the population.
RESULTS
Prevalence of Health-Related Risk Factors in the United States and their Disparities
In Table 2, we present the prevalence of the risk factors and how they vary by age, demo-

7

graphic group and socioeconomic status. We test whether differences within each group are statistically significant from the base category (age 25-44, NH White, BA or more, top income quartile) and denote these with asterisks.
The risk factors are listed in order of their prevalence in the overall U.S. adult population
based on the PSID data. Hypertension is the most prevalent factor, at 33%. Hypertension increases
with age, with 59% of those 65 and older having been diagnosed. Diabetes and asthma are the
second and third most prevalent risk factors at 12% and 11%, respectively. Diabetes increases with
age, with only 4% of those in early adulthood (25-44 years old) having been diagnosed while one
quarter (23%) of those 65 and older have the disease. In contrast, asthma declines with age, going
from 12% for those 25-44 years old to 9% for those 65 and older. Some 9% of the adult population
has been diagnosed with cancer and its prevalence rises with age up to 1 in 5 (21%) of those 65
and older. Five percent of adults are severely obese and there is little variation by age. Among the
remaining health-related risk factors, the prevalence ranges from 1% to 6%, all increasing with
age. Finally, 10% of adults report being hospitalized in the preceding year for one night or more,
including 17% of those 65 and older.
As the other columns in Table 2 make clear, there is an unequal distribution of these healthrelated risk factors by race-ethnicity, educational attainment, and income. Compared to NH
Whites, NH Blacks have higher prevalence of most of the risk factors for COVID-19, with nearly
all of these differences being statistically significant. For example, NH Blacks are one third more
likely to have been diagnosed with hypertension than NH Whites (44% vs 33%). Cancer is more
prevalent for NH Whites than NH Blacks (10% for NH Whites vs 6% for NH Blacks). Neurological conditions are also more prevalent for NH Whites (3%) than NH Blacks (2%). Prevalence
rates for the risk factors listed in Table 2 are the same or lower for Hispanic adults than NH Whites
(or NH Blacks), except for diabetes, which is more prevalent for Hispanics than NH Whites. The
prevalence of hypertension is 23% for Hispanics compared to 33% for NH Whites. These raceethnic differences have been documented in prior studies (32-34).
The prevalence of risk factors is also quite different by education. Adults in the United
States with no more than a high school education have higher rates for almost all risk factors compared to adults with a college degree. For example, 39% suffer from hypertension compared to
one quarter (26%) of the higher educated group. Two notable exceptions to this pattern are cancer
and chronic kidney disease, which do not vary by education.

8

Adults in the bottom quartile of household income have higher rates for every risk factor
compared to those in the top quartile, and these differences are sizeable. Compared to those in the
top income quartile, those in the bottom quartile are about twice as likely to have been diagnosed
with hypertension (25% vs 46%), diabetes (8% vs 18%) and asthma (9% vs 15%), are about three
times more likely to have had a heart attack (2% vs 7%) or a stroke (2% vs 7%) and are six times
more likely to suffer from lung disease (2% vs 12%). Those in the lowest income group are three
times more likely to have had an in-patient hospitalization in the past year (6% vs 18%).
Table 2 also shows that the prevalence of nearly all risk factors increases with age. The
total number of risk factors also increases with age. In Figure 2, we display the percent of the
population with 0, 1, 2 and 3 or more of the risk factors listed in Table 2 across three age groups.
Among all adults, 47% have 0 risk factors, while 13% have 2 and another 13% have 3 or more, for
an average of 1.02 risk factors in the U.S. adult population. The number of risk factors increases
across age groups, with 64% of adults 25-44 having no risk factors while only 20% of those 65
and older having none. Only 3% of younger adults have 3 or more risk factors, while 28% of those
65 and older have 3 or more.
We showed that the distribution of age varies across race-ethnicity, education, and income
groups in our sample. Appendix Tables C-1 - C-3 report the prevalence of each of the risk factors
by race-ethnicity, socioeconomic status, and age. Differences in the prevalence of hypertension
between NH Blacks and NH Whites and by education and income emerge early in life and are
large by midlife. Hispanics have a health advantage in hypertension in midlife but the prevalence
of diabetes among Hispanics is greater than for NH Whites at ages 45-64. There are disparities
across nearly all conditions for less-educated and low-income Americans that are similar to those
for NH Blacks. These disparities become large in midlife though there are statistically significant
differences by education and income in the prevalence of nearly all health conditions among those
age 25-44.
In Figure 3, we present the distribution of the number of risk factors for the overall population and by age across race-ethnic groups, educational attainment, and household income, using
the same format as Figure 2. Consistent with the disparities by race-ethnicity in individual risk
factors, among all adults, NH Blacks are more likely to have three or more risk factors compared
to NH Whites (18% vs 13%), while only 7% of Hispanics have such a high number (Figure 3(a),
25+ age group). Among adults with 12 years of schooling or less, 17% have 3 or more risk factors,

9

compared to just 7% of those with a college degree (Figure 3(b), 25+ age group). Finally, the
differences in numbers of risk factors are particularly dramatic by income, with 24% of adults in
the bottom quartile of household income having 3 or more risk factors compared to only 6% among
those in the top income quartile (Figure 3(c), 25+ age group). All of the differences highlighted
above are statistically significant.
Figure 3 also shows the distribution of the number of risk factors by age across race-ethnicity, education, and household income. For NH Blacks, those with 12 years of schooling or less,
and those in the bottom quartile of income, risk factors accumulate at earlier ages. For example,
by age 45-64, 41% of NH Blacks have two or more risk factors compared to only 25% of NH
Whites. On average, fewer adults age 45-64 with household incomes in the top income quartile
have two or more conditions (16%) than those age 25-44 in the bottom income quartile (19%), and
fewer adults in the oldest group with household incomes in the top quartile have two or more
conditions (38%) than those in middle age (45-64) with incomes in the bottom quartile (45%). All
of these differences highlight above are statistically significant.
Disparities in Relative Vulnerability to Severe Illness in the United States
In Figure 4, we display median values of the relative vulnerability index by numbers of
risk factors for the three age groups and the overall adult population. 6 Recall that the index
measures the odds of having severe illness from COVID-19 relative to a 30 year-old female with
no risk factors. The median value is 4.08 (not shown in Figure 4). As seen in Figure 4, relative
vulnerability varies substantially by number of risk factors and by age. Among all ages (the 25+
group), those with no risk factors are 1.9 times more vulnerable compared to a 30 year-old female.
As the number of risk factors increases, relative vulnerability increases, with the median risk of
individuals with 3 or more risk factors at 47.9 times greater odds of becoming severely ill. On
average, individuals in this high-risk group have 3.8 risk factors and 9% have 5 or more risk factors. Individuals with particular risk factors are also likely to have more risk factors. For example,
adults with hypertension had, on average, 1.2 other risk factors, while those who did not have
hypertension had an average of 0.4 risk factors.
Figure 4 also makes clear that the increasing numbers of risk factors for those at older ages
displayed in Figure 2, result in a progressive increase in relative vulnerability across age groups.

6

Similar patterns emerge when using means and medians.

10

For example, individuals who are 65 and older and who have 3 or more risk factors are 70 times
more likely to become severely ill than a 30 year-old healthy (no risk factors) female. Among
individuals in this high-risk group, 25% have 5 or more risk factors and half are age 75 or older.
While this estimate of relative vulnerability is extraordinarily high, the relative magnitudes of the
differences by age and number of risk factors illustrate how the accumulation of risk factors with
age makes many older Americans much more vulnerable to COVID-19.
Figure 4 also illustrates how having multiple risk factors heightens the vulnerability to
severe illness from COVID-19 at any age. For example, adults 65 and older with no risk factors
(20% of that age group) have a median vulnerability that is 5.6 times that of the reference person
(30 year-old female with no risk factors). This is almost the same relative vulnerability to severe
illness as for 25-44 year-olds with 2 risk factors (6.6 relative vulnerability and 7% of the younger
age group). In fact, the relative vulnerability of those 65 and older with no risk factors is more than
3 times lower than the relative vulnerability of 25-44 year-olds with 3 or more risk factors. This
comparison illustrates both the disturbing consequences of younger adults having multiple risk
factors and the apparent benefits to older age adults of having fewer risk factors with respect to
vulnerability of becoming severely ill from COVID-19.
The results in Figure 4 for relative vulnerability represent the differences in the distributions of numbers of risk factors for different age groups and the impact that particular risk factors
have on relative vulnerability at different ages. Recall for example that Figure 1 shows that hypertension and lung disease have the largest impacts on the relative vulnerability scores at all ages
and that the impacts of both increased markedly with age. At the same time, as we noted in our
discussion of Table 2, the prevalence of hypertension in the U.S. population is high (33%) and
increases across age groups, while, relatively speaking, the prevalence of lung disease is much
lower (6%) and increases less markedly with age. Thus, the relative vulnerability index allows one
to characterize the combined impact of (and differences in) the prevalence of risk factors and their
impact on population-level vulnerability, providing greater insight than simply looking at the prevalence of risk factors can provide.
In Figure 5 we display the median relative vulnerability scores by age for race-ethnic, education, and income groups. Recall that in Figure 3(a) we found that NH Blacks have more risk
factors, on average, than NH Whites, and that NH Blacks have a higher number of risk factors
after age 45 than NH Whites. The higher prevalence of hypertension among NH Blacks contributes

11

to this race differences in the number of risk factors (see Appendix Table C-1). We also found that
the prevalence of most risk factors is lower among Hispanics, other than diabetes (see Appendix
Table C-1). But diabetes has a smaller effect on VI than hypertension (Figure 1). As shown in
Figure 5(a), by age 45, sizeable differences in relative vulnerability to severe illness emerge between NH Blacks and NH Whites and these gaps remain large at older ages. Hispanics have lower
relative vulnerability at all ages. Across the whole sample (25+), the difference in relative vulnerability between NH Blacks and NH Whites is muted. This is due to the age distributions shown in
Table 1 where those who are age 65 and older make up 28% of the population of NH Whites but
only 17% of the population of NH Blacks.
Figure 5(b) has the same format for showing the median relative vulnerability among adults
with a high school degree or less education and those who are college educated. On average, relative vulnerability is 60% higher for those with high school or less (5.4) than for those with a college
degree (3.3), and this gap by education emerges in midlife.
Finally, Figure 5(c) presents the median vulnerability for those in the bottom and top quartiles of household income. Among all adults (ages 25+), there is nearly a 3-fold difference in relative vulnerability, with those in the bottom quartile of income having 9.4 higher odds of severe
illness compared to the reference person, while for those in the top income quartile, the odds are
only 3.4 times higher. This gap by income in relative vulnerability emerges among middle-age
adults and reflects large differences in prevalence of risk factors (Figure 3(c)) by income.
A full assessment of the relationships among race-ethnicity, education, and income is beyond the scope of this paper. But in light of the correlations among these dimensions of population
subgroups, we examined differences in vulnerability in midlife across race-ethnic groups within
education and income groups, the differences in vulnerability across education within race-ethnic
and income groups, and the differences in vulnerability across income within race-ethnic and education groups (see Appendix Table C-4). Taking account of socioeconomic differences mutes,
but does not eliminate the greater vulnerability of NH Blacks compared to NH Whites. Hispanicsâ€™
health advantage in vulnerability is pronounced among low-income adults. Education and income
differences in vulnerability remain large but are reduced within race-ethnic groups.
DISCUSSION
The DeCaprio et al. model predicts hospitalizations due to respiratory infections prior to

12

the COVID-19 outbreak and as a function of age and preexisting health risk factors. How accurately does this model predict actual disparities by age, race-ethnicity, and socioeconomic status
in hospitalizations associated with the coronavirus? We address this question using early surveillance data from the CDC.
Hospitalization is influenced by two channels: exposure and susceptibility to infection and
its complications. Each may differ in their determinants and, thus, may differ across particular
viruses and diseases. Susceptibility and complications are likely to depend heavily on the sort of
preexisting conditions included in the DeCaprio et al. model. Evidence from New York City indicates that, conditional on testing positive for COVID-19, the comorbidities and the demographic
characteristics of patients hospitalized with COVID-19 are similar to those admitted with other
acute respiratory infections (11). However, exposure to COVID-19 likely differs by factors other
than age and preexisting health conditions. Separating these channels empirically is beyond the
scope of available data. However, we can compare the modelâ€™s predictions for disparities in vulnerability presented above with the distributions of available characteristics of those that have been
hospitalized to date with severe complications from the coronavirus.
Garg et al. (20) report on the prevalence of preexisting health conditions disaggregated by
age for laboratory-confirmed COVID-19 hospitalizations during March 2020. We predict VI based
on the average conditions of these hospitalized patients overall and by age group. We compare VI
based on the average preexisting conditions of hospitalized patients to the distribution of VI in the
PSID. Appendix D describes these calculations in more detail.
The VI of hospitalized patients of all ages is 8.51, which corresponds to the 66% percentile
of VI for the PSID sample. For hospitalized patients between 18-49 it is 3.04, for those age 50-64
it is 7.87, and for those 65 and older it is 23.14, corresponding to the 48th percentile, the 65th percentile, and the 84th percentile of the PSID vulnerability distribution, respectively. This correspondence between the VI for actual COVID-19 hospitalizations and that in the PSID based on the
DeCaprio et al. model is consistent with our findings that older adults with multiple preexisting
conditions in the general population are more vulnerable to severe complications requiring hospitalization and that a substantial fraction of adults in midlife are also vulnerable to hospitalization.
For younger adults, our VI estimates based on health conditions correspond less well to actual
COVID-19 hospitalizations. This lack of correspondence suggests that, compared to older adults,

13

exposure to infection is relatively more important for younger adults than susceptibility to infection and complications.
The distinction between exposure and infection also sheds light on race-ethnic disparities
in observed hospitalizations. The CDC data indicate a dramatic over-representation of NH Blacks
among hospitalized patients while we find no NH Black-NH White difference in median VI when
all ages are combined (see Figure 5a) (21). Within age groups, we report that NH Blacks have
higher VI. These patterns are consistent with higher rates of exposure among NH Blacks than NH
Whites that are compounded by disparities in health conditions within age groups. Relative to NH
Whites, Hispanics are also overrepresented among patients hospitalized with COVID-19, both
overall and after adjusting for age (21). We report that Hispanics have lower median VI than NH
Whites both overall and within age groups, and thus rates of exposure are likely higher for Hispanics than NH Whites.
CONCLUSION
This paper provides the first nationally representative estimates of vulnerability to severe
complications from COVID-19 overall and across race-ethnicity and socioeconomic status. We
use the PSID to examine the prevalence of specific health conditions associated with complications
from COVID-19 and to calculate, for each individual, an index of the risk of severe complications
from respiratory infections developed by DeCaprio et al. (23) based on these health conditions.
We show large disparities across race-ethnicity and socioeconomic status in the prevalence of conditions associated with adverse outcomes, and in the overall risk of severe complications. Moreover, we show that these disparities emerge early in life, prior to age 65.
Consistent with the surveillance data, our results suggest a higher risk of adverse outcomes
in midlife for non-Hispanic Blacks. Education and income are not included in the surveillance data
but our results further suggest that adults with a high school degree or less and low-income Americans are also at high risk of adverse outcomes starting in midlife. These results are especially
important as states and municipalities start to reopen businesses and public services as recent evidence suggests that disadvantaged groups are less likely to be able to socially distance at work
(27). The evidence that we present shows large disparities in preexisting health conditions among
working-age adults for these same groups. Combined, these results suggest that localities with high
levels of poverty, a high percentage of African-Americans, or a high concentration of less-educated
adults face potentially devastating effects of the virus.

14

There are caveats to this study. First, we are likely understating the disparities in the risk
for severe complications from COVID-19 by race-ethnicity, education, and income based on
preexisting health conditions because disadvantaged populations have higher rates of undiagnosed
diseases (35-39), because socioeconomic status and race-ethnicity affect whether an individual is
hospitalized regardless of preexisting conditions (40), and because among those diagnosed with a
disease, rates of control for some diseases are lower for disadvantaged populations (36, 37, 39,
41).
Second, there is more work to be done exploring interactions of race-ethnicity, education,
and income. There is ample evidence of large mortality gaps across these groups (42), and this is
an area for more extensive exploration.
Finally, we have discussed why disparities in the risk of severe complications based on
preexisting health conditions does not capture the full risk of hospitalization and death from
COVID-19 because it does not account for factors influencing exposure to the virus or access to
high quality care. All of these factors, including the preexisting health conditions we examine, are
influenced by systemic inequalities in society and in our health care system. Such inequalities will
make it difficult to isolate the influence of health conditions on disparities in the overall effect of
COVID-19 pandemic on the U.S. population but starting to disentangle these effects is crucially
important.

15

REFERENCES
1.

2.

3.

4.
5.
6.
7.

8.

9.

10.

11.

12.
13.

14.

15.

16.

A. Clark et al., Global, regional, and national estimates of the population at increased risk
of severe COVID-19 due to underlying health conditions in 2020: a modelling study. The
Lancet Global Health 10.1016/S2214-109X(20)30264-3 (2020).
Center for Disease Control and Prevention (2020) COVID-19 Laboratory-Confirmed
Hospitalization. Preliminary data as of June 06, 2020.
(https://gis.cdc.gov/grasp/COVIDNet/COVID19_5.html).
S. Richardson et al., Presenting Characteristics, Comorbidities, and Outcomes Among
5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 323,
2052-2059 (2020).
M. Arentz et al., Characteristics and Outcomes of 21 Critically Ill Patients With COVID19 in Washington State. JAMA 323, 1612-1614 (2020).
P. K. Bhatraju et al., Covid-19 in Critically Ill Patients in the Seattle Region â€” Case
Series. New England Journal of Medicine 382, 2012-2022 (2020).
M. J. Cummings et al., Epidemiology, clinical course, and outcomes of critically ill
adults with COVID-19 in New York City: a prospective cohort study. The Lancet (2020).
A. Emami, F. Javanmardi, N. Pirbonyeh, A. Akbari, Prevalence of Underlying Diseases
in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis. Arch
Acad Emerg Med 8, e35-e35 (2020).
G. Grasselli et al., Baseline Characteristics and Outcomes of 1591 Patients Infected With
SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA 323, 1574-1581
(2020).
A. Haimovich et al., Development and validation of the COVID-19 severity index (CSI):
a prognostic tool for early respiratory decompensation. medRxiv
10.1101/2020.05.07.20094573, 2020.2005.2007.20094573 (2020).
X. Zhao et al., Incidence, clinical characteristics and prognostic factor of patients with
COVID-19: a systematic review and meta-analysis. medRxiv
10.1101/2020.03.17.20037572, 2020.2003.2017.20037572 (2020).
C. M. Petrilli et al., Factors associated with hospital admission and critical illness among
5279 people with coronavirus disease 2019 in New York City: prospective cohort study.
BMJ 369, m1966 (2020).
J. A. Siordia, Epidemiology and clinical features of COVID-19: A review of current
literature. Journal of Clinical Virology 127, 104357 (2020).
J. Yang et al., Prevalence of comorbidities and its effects in patients infected with SARSCoV-2: a systematic review and meta-analysis. International Journal of Infectious
Diseases 94, 91-95 (2020).
Z. Wu, J. M. McGoogan, Characteristics of and Important Lessons From the Coronavirus
Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases
From the Chinese Center for Disease Control and Prevention. JAMA 323, 1239-1242
(2020).
A. Case, A. Deaton, Rising morbidity and mortality in midlife among white non-Hispanic
Americans in the 21st century. Proceedings of the National Academy of Sciences 112,
15078-15083 (2015).
R. Chetty et al., The Association Between Income and Life Expectancy in the United
States, 2001-2014. JAMA 315, 1750-1766 (2016).

16

17.

18.

19.

20.

21.

22.

23.
24.

25.

26.
27.

28.
29.
30.
31.

32.

J. Currie, H. Schwandt, Inequality in mortality decreased among the young while
increasing for older adults, 1990â€“2010. Science 10.1126/science.aaf1437, 708-712
(2016).
M. L. Adams, J. Grandpre, D. L. Katz, Updated estimates of comorbidities associated
with risk for COVID-19 complications based on US data. medRxiv
10.1101/2020.05.02.20088781, 2020.2005.2002.20088781 (2020).
M. A. Raifman, J. R. Raifman, Disparities in the Population at Risk of Severe Illness
From COVID-19 by Race/Ethnicity and Income. American Journal of Preventive
Medicine https://doi.org/10.1016/j.amepre.2020.04.003 (2020).
S. Garg et al., Hospitalization Rates and Characteristics of Patients Hospitalized with
Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30,
2020. Morbidity and Mortality Weekly Report 69, 458-464 (2020).
Center for Disease Control and Prevention (2020) COVIDView, A Weekly Surveillance
Summary of U.S. COVID-19 Activity, Week 23 ending June 6, 2020.
(https://gis.cdc.gov/grasp/COVIDNet/COVID19_5.html).
Center for Disease Control and Prevention (2020) Provisional Death Counts for
Coronavirus Disease (COVID-19): Weekly State-Specific Data Updates, NCHS.
(https://data.cdc.gov/NCHS/Provisional-Death-Counts-for-Coronavirus-Disease-C/pj7my5uh).
D. DeCaprio et al., Building a COVID-19 Vulnerability Index. medRxiv
10.1101/2020.03.16.20036723, 2020.2003.2016.20036723 (2020).
K. M. J. Azar et al., Disparities In Outcomes Among COVID-19 Patients In A Large
Health Care System In California. Health Affairs 10.1377/hlthaff.2020.00598,
10.1377/hlthaff.2020.00598 (2020).
N. W. Papageorge et al., Socio-Demographic Factors Associated with Self-Protecting
Behavior during the Covid-19 Pandemic. National Bureau of Economic Research
Working Paper Series No. 27378 (2020).
A. Wozniak (2020) Disparities and Mitigation Behavior during COVID-19. (Federal
Reserve Bank of Minneapolis).
S. Mongey, L. Pilossoph, A. Weinberg, Which Workers Bear the Burden of Social
Distancing Policies? National Bureau of Economic Research Working Paper Series No.
27085 (2020).
Center for Disease Control and Prevention, CDC Health Disparities and Inequalities
Report â€” United States, 2013. Morbidity and Mortality Weekly Report 63 (2013).
H. Mead et al. (2008) Racial and Ethnic Disparities in U.S. Health Care: A Chartbook.
(The Commonwealth Fund).
PSID Main Interview User Manual: Release 2019 (2019) (Institute for Social Research,
University of Michigan).
K. A. McGonagle, R. F. Schoeni, N. Sastry, V. A. Freedman, The Panel Study of Income
Dynamics: overview, recent innovations, and potential for life course research.
Longitudinal and Life Course Studies; Vol 3, No 2 (2012): Longitudinal and Life Course
StudiesDO - 10.14301/llcs.v3i2.188 (2012).
R. P. Hertz, A. N. Unger, J. A. Cornell, E. Saunders, Racial Disparities in Hypertension
Prevalence, Awareness, and Management. Archives of Internal Medicine 165, 2098-2104
(2005).

17

33.

34.
35.

36.
37.

38.

39.

40.

41.

42.
43.
44.
45.
46.
47.
48.
49.

50.

M. T. Hicken, H. Lee, J. Morenoff, J. S. House, D. R. Williams, Racial/Ethnic Disparities
in Hypertension Prevalence: Reconsidering the Role of Chronic Stress. American Journal
of Public Health 104, 117-123 (2013).
National Center for Health Statistics (2019) Health, United States, 2018. (National Center
for Health Statistics (US)).
S. H. Barcellos, D. P. Goldman, J. P. Smith, Undiagnosed Disease, Especially Diabetes,
Casts Doubt On Some Of Reported Health â€˜Advantageâ€™ Of Recent Mexican Immigrants.
Health Affairs 31, 2727-2737 (2012).
A. V. Chobanian, The Hypertension Paradox â€” More Uncontrolled Disease despite
Improved Therapy. New England Journal of Medicine 361, 878-887 (2009).
R. Pleasants, I. Riley, D. Mannino, Defining and targeting health disparities in chronic
obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary
Disease 11, 2475-2496 (2016).
J. P. Smith, Nature and causes of trends in male diabetes prevalence, undiagnosed
diabetes, and the socioeconomic status health gradient. Proceedings of the National
Academy of Sciences 104, 13225-13231 (2007).
L. Zallman et al., Undiagnosed and Uncontrolled Hypertension and Hyperlipidemia
among Immigrants in the US. Journal of Immigrant and Minority Health 15, 858-865
(2013).
E. C. Lowcock, L. C. Rosella, J. Foisy, A. McGeer, N. Crowcroft, The Social
Determinants of Health and Pandemic H1N1 2009 Influenza Severity. American Journal
of Public Health 102, e51-e58 (2012).
P. Chatterji, H. Joo, K. Lahiri, Racial/Ethnic- and Education-Related Disparities in the
Control of Risk Factors for Cardiovascular Disease Among Individuals With Diabetes.
Diabetes Care 35, 305 (2012).
A. Case, A. Deaton, Deaths of despair and the future of capitalism (Princeton University
Press, Princeton, 2020).
N. E. Insolera, V. A. Freedman, Comparing Health Estimates in the PSID and NHIS,
2001-2015. PSID Technical Series Paper 17-01 (2017).
National Center for Health Statistics (2020) Interactive Summary Health Statistics for
Adults. (https://www.cdc.gov/nchs/nhis/ADULTS/www/index.htm).
V. A. Freedman, B. H. McFall, L. Ryan, Adding the AD8 Dementia Screen to the Panel
Study of Income Dynamics. PSID Technical Series Paper 19-01 (2019).
Center for Disease Control and Prevention (2020) Data & Statistics on Sickle Cell
Disease. ed 2020 (https://www.cdc.gov/ncbddd/sicklecell/data.html).
National Kidney Foundation (2020) Kidney Disease: The Basics.
(https://www.kidney.org/news/newsroom/factsheets/KidneyDiseaseBasics).
National Center for Health Statistics (2020) Disease of the Week: Pneumonia.
(https://www.cdc.gov/dotw/pneumonia/index.html).
UpToDate (2020) Acute rheumatic fever: Epidemiology and pathogenesis.
(https://www.uptodate.com/contents/acute-rheumatic-fever-epidemiology-andpathogenesis).
Center for Disease Control and Prevention (2020) Chronic Liver Disease and Cirrhosis.
(https://www.cdc.gov/nchs/fastats/liver-disease.htm).

18

Table 1. Percent of Demographic and SES Groups by Age across Age Categories & Mean Age
Percent across Age Categories Percent within Age Categories
Percent,
All Ages
(25+)
25-44
45-64
65+
25-44
45-64
65+
Overall
38
38
24

Mean
Age
51.9

Gender
Female
Male

37
39

38
38

26
23

51
49

52
48

55
45

52
48

52.4
51.5**

7,140
6,010

Race and Ethncity
NH White
NH Black
Hispanic
NH Other

33
42
52
52

38
41
36
32

28
17
13
15

64
12
18
7

72
12
12
4

83
7
7
3

71
11
13
5

53.6
49.2***
46.5***
47.4***

7,082
4,158
1,464
446

Education
HS or less
Some college
BA or more

32
39
43

40
38
36

28
23
22

32
25
43

41
24
36

44
22
34

38
24
38

54.3***
51.2**
50.1

5,262
3,482
4,406

Sample
sizes
13,150

Household Income
Bottom Quartile
31
33
37
15
16
27
18
56.6***
2,550
Second Quartile
40
31
29
24
18
27
23
52.3***
3,166
Third Quartile
41
36
23
30
26
26
28
50.5
3,660
Top Quartile
37
48
15
31
40
20
32
50.3
3,774
Sample sizes
6,808
4,392
1,950
Data Source: 2017 Wave, PSID. Sample: PSID heads and spouses, 25 years and older. Weights: PSID individual crosssection weights.
Notes: Asterisks (*) are for tests of age of a subgroup being significantly different from base group, where: * Pvalue â‰¤ 0.10; ** P-value â‰¤ 0.05; *** P-value â‰¤ 0.01. Base groups are female, NH White, BA or more, top income
quartile.

19

Table 2. Age, Race-Ethnicity, and SES in Prevalence (%) of Health-Related Risk Factors
Age
Race-ethnicity
Risk factor
Hypertension
Diabetes
Asthma
Hospitalization
Cancer
Lung disease
Heart disease
Severe obesity
Heart attack
Stroke
Neurological conditions
Chronic Kidney Disorder
Sample Sizes

Overall
33
12
11
10
9
6
6
5
4
3
3
1
13,150

25-44
14
4
12
7
2
3
1
5
1
1
1
<1
6,808

45-64
35***
14***
10**
9**
7***
6***
5***
6
4***
3***
2***
1**
4,392

65+
59***
23***
9***
17***
21***
11***
14***
4*
10***
8***
5***
1***
1,950

NH
White
33
11
11
10
10
6
6
4
5
3
3
1
7,082

NH
Black
44***
16***
13**
12*
6***
7
7
9***
5
6***
2**
1
4,158

Education

HS or
Hispanic less
23***
39***
14*
15***
9**
11*
9
12***
5***
9
3***
9***
2***
7***
5
6***
2***
6***
2*
4***
2***
4***
<1*
1
1,464
5,262

BA or
more
26
9
10
7
9
3
4
3
2
2
1
1
4,406

Household Income
Bottom
Quartile
46***
18***
15***
18***
11**
12***
11***
7***
7***
7***
6***
1
2,550

Top
Quartile
25
8
9
6
8
2
3
3
2
2
0
0
3,774

Data Source: 2017 Wave, PSID. Sample: PSID heads and spouses, 25 years and older. Weights: PSID individual cross-section weights.
Income quartiles are determined across households using family weights.
Notes: Asterisks (*) are for tests of risk factors of a subgroup being significantly different from base group, where: * P-value â‰¤ 0.10; ** Pvalue â‰¤ 0.05; *** P-value â‰¤ 0.01. Base groups are 25-44, NH White, BA or more, top income quartile.

20

21

22

23

24

25

26

27

Appendix A: Comparison of PSID Sample with Current Population Survey (CPS)
Table A-1. Percent of Demographic and SES Groups by Age across Age Categories & Mean Age for PSID Sample
Percent across Age Categories
Percent within Age Categories
Prop (%).,
All Ages
Mean Sample
(25+)
Age
sizes
25-44
45-64
65+
25-44
45-64
65+
Overall
37.6
38.1
24.3
51.9 13,150
Gender
Female
Male

37
39

38
38

26
23

51
49

52
48

55
45

52
48

52.4
51.5

7,140
6,010

Race and Ethncity
NH White
NH Black
Hispanic
NH Other

33
42
52
52

38
41
36
32

28
17
13
15

64
12
18
7

72
12
12
4

83
7
7
3

71
11
13
5

53.6
49.2
46.5
47.4

7,082
4,158
1,464
446

Education
HS or less
32
40
28
32
41
44
38
54.3
Some college
39
38
23
25
24
22
24
51.2
BA or more
43
36
22
43
36
34
38
50.1
Sample sizes
6,808
4,392
1,950
Data Source: PSID, 2017 Wave. Sample: Household heads and spouses, ages 25 and older. Weights: PSID
individual cross-section weights.

5,262
3,482
4,406

Table A-2. Percent of Demographic and SES Groups by Age across Age Categories & Mean Age for CPS Sample
Percent across Age Categories
Percent within Age Categories
Prop (%).,
All Ages
Mean Sample
(25+)
Age
sizes
25-44
45-64
65+
25-44
45-64
65+
Overall
34.8
40.3
24.9
52.4 101,462
Gender
Female
Male

35
35

40
41

25
25

53
47

52
48

54
46

53
47

52.5
52.4

53,840
47,622

Race and Ethncity
NH White
NH Black
Hispanic
NH Other

30
38
49
47

41
43
38
37

29
20
13
16

60
12
19
10

70
11
12
7

80
9
7
5

69
11
13
8

54.3
50.6
46.8
48.1

65,151
11,378
15,976
8,957

Education
HS or less
29
41
30
30
38
44
37
55.0 38,019
Some college
35
41
23
28
28
25
27
51.8 27,560
BA or more
40
39
21
42
35
31
36
50.4 35,883
Sample sizes
38,732
40,401
22,329
Data Source: CPS, 2017 Annual Social & Economic Supplement. Sample: Household heads and spouses, ages 25
and older. Weights: ASEC weights.

28

Appendix B: Formula for the DeCaprio et al. Model and Corresponding Risk Factors in the
PSID
In Table B-1, we provide the variable names and question wording from the 2017 Wave of
the PSID for these risk factors. Table B-2 displays the variables used and coefficient estimates for
the DeCaprio et al. Model 7 along with the corresponding health-related risk factors that are available in the PSID.
PSID staff has compared self-reports about health conditions to the gold-standard for selfreported health conditions, the National Health Interview Survey (NHIS), to evaluate the quality
of the PSID data. The PSID estimates for nearly all measures are close to those in the NHIS, a
personal household interview study that has been used by the National Center for Health Statistics
to monitor Americansâ€™ health since 1957. PSID estimates also show time trends consistent with
those from the NHIS (43). There are two exceptions. Chronic kidney disease is twice as common
in the NHIS than in the PSID, in which 1% report kidney disease (44). The PSID information about
kidney disease, unlike all other conditions we examine, comes from reports about â€œother serious
chronic conditions,â€ without a specific prompt for kidney-related conditions. The NHIS information is obtained from a specific question about â€œweak or failing kidneys,â€ and specific questions
are more likely to elicit these reports. The other exception is the prevalence of â€œneurocognitive
conditions,â€ which we indicate by whether sample members were ever told by a doctor or health
professional that they had â€œpermanent loss of memory or mental ability.â€ However, the PSID selfreported measure has external validity as demonstrated by its consistent positive association with
the Eight Item Interview to Differentiate Aging and Dementia Screen (AD8) (45). Though Insolera
& Freedman (43) validate estimates of obesity (BMI â‰¥ 30) with NHIS, the estimates of severe
obesity (BMI â‰¥ 40) in Table 2 match those in the BRFSS. Rates of hypertension by race-ethnicity
in the PSID match crude rates from NHANES almost exactly (34).
As noted in the text, the PSID does not have all of the variables that DeCaprio et al.(23)
used in the estimation of the logistic regression for this Survey Model. In our implementation of
the model, we assumed that the indicators for the risk factors not collected in the PSID had a value
of 0. As we note in the text, this means that our estimates of the vulnerability index scores of
individuals in the PSID understate their risk of serious disease. The extent of this understatement
and how the extent of understatement will vary in the population depends on both the prevalence
of the particular risk factors in the population and their marginal impacts on the vulnerability index
score, which is determined by the coefficients on these variables.
The following conditions are not included: sickle cell disease (SCD), hemodialysis, pneumonia, rheumatic heart disease, and liver disease (cirrhosis of the liver). The prevalence and/or
incidence of most of these conditions is low. SCD affects approximately 100,000 Americans. It is
more common among Blacks, than other race-ethnic groups, but occurs among under 0.3% of
Black births. (46). In 2017, 746,557 Americans had kidney failure and needed dialysis or a kidney
transplant to survive (47). About 250,000 people in the United States seek care each year in a
hospital due to pneumonia (48). Finally, the incidence of rheumatic fever is less than 2 cases per
7

The first two columns of Table B-1 are taken from Table 4 of DeCaprio et al. (2020) for their Survey Model. CCSR
codes are provided for each of the conditions listed in the model.

29

100,000 school-age children and most cases occur in children 5 â€“ 15 years of age (49). The prevalence of liver disease is higher. About 4.5 million adults are diagnosed with liver disease, with a
prevalence of 1.8% (50). Thus, with the exception liver disease (cirrhosis of the liver), the risk
factors in the DeCaprio et al. model, but not in the PSID, are of very low prevalence and/or incidence. Liver disease has a very low coefficient estimate and a small interaction effect with age.
Sickle cell anemia, which has a fairly sizeable impact in the calculation of the index for NH Blacks
at ages up to around 50 has a low prevalence in the population. However, because the prevalence
of Sickle cell anemia cannot be determined for our PSID sample, the values for the vulnerability
index in the PSID data will be (slightly) understated, on average, for NH Blacks and some Hispanics.

30

Table B-1. Health-Related Risk Factors and Other Variables, Variable Names, and Question Wording from the 2017 Wave of the
PSID
Risk Factor/Variable
Age
Gender
Past Hospitalization
Lung Disease

PSID Variable
ER34504
ER32000

Question Wording
What is your current age?
What is your gender?

ER68511, ER69638
ER68454, ER69581

Asthma
Severe Obesity

ER68449, ER69576
ER68568, ER68569,
ER69695, ER69696,
ER68566, ER68567

Were you a patient in a hospital overnight or longer at any time during 2016?
Has a doctor or other health professional ever told you that you had chronic lung disease
such as bronchitis or emphysema?
Has a doctor or other health professional ever told you that you had asthma?
Constructed BMI using height and weight variables and designating severely obese if BMI â‰¥
40

Diabetes

ER68459, ER69586

Hypertension

ER68444, ER69571

Heart Disease

ER68439, ER69566

Heart Attack
Stroke
Kidney Disease

ER68433, ER69560
ER68427, ER69554
ER68498, ER69625

Cancer

ER68479, ER69606

Neurological condition

ER68469, ER69596

Has a doctor or other health professional ever told you that you had diabetes or high blood
sugar?
Has a doctor or other health professional ever told you that you had high blood pressure or
hypertension?
Has a doctor or other health professional ever told you that you had coronary heart disease,
angina, congestive heart failure?
Has a doctor or other health professional ever told you that you had a heart attack?
Has a doctor or other health professional ever told you that you had a stroke?
Is there any other serious, chronic condition that a doctor or other health professional ever
told you had? [ 3: Kidney disease]
Has a doctor or other health professional ever told you that you had cancer or a malignant
tumor?
Has a doctor or other health professional ever told you that you had permanent loss of
memory or mental ability?

31

Table B-2. Risk Factors & Other Conditions from the DeCaprio et al. Model
Coefficient
Estimate
-6.740
0.041
0.171
0.682
0.413

Variables in DeCaprio et al. Survey Model
intercept
Age
Male
Prior Admissions
Prior ER Visits
Chronic obstructive pulmonary disease
(COPD) or emphysema, cystic fibrosis, or
chronic bronchitis
Asthma
Obesity (BMI â‰¥ 40)
Diabetes (other than when you were pregnant)
Hypertension (or high blood pressure)
Congestive Heart Failure
Heart attack
Rheumatic heart disease
Stroke
Sickle cell anemia/HIV infection/Transplant
Chronic kidney disease
Hemodialysis
Liver disease
Pneumonia, acute bronchitis, influenza or
other acute respiratory infection
Cancer
Neurocognitive conditions
Pregnancy, childbirth & puerperium
COPD x Age
Asthma x Age
Obesity x Age
Diabetes x Age
Hypertension x Age
Congestive heart failure x Age
Myocardial infarction x Age
Rheumatic heart disease x Age
Stroke x Age
Sickle cell/HIV/Transplant x Age
Chronic kidney disease x Age
Hemodialysis x Age
Liver disease x Age
Pneumonia, acute bronchitis, influenza or
other acute respiratory infection x Age
Cancer x Age
Neurocognitive conditions x Age
Pregnancy, childbirth & puerperium x Age

Age
Male
Hospitalized

1.167
1.393
0.935

Lung Disease
Asthma
Severe Obesity (BMI â‰¥ 40)

0.096
0.832
0.982
0.159
0.788
0.285
2.582
0.966
1.369
0.055

Diabetes
Hypertension
Heart Disease
Heart Attack

0.696
1.091
0.294
0.789
-0.002
-0.015
-0.004
0.000
0.005
-0.007
0.003
-0.008
-0.003
-0.028
-0.008
-0.018
0.001
-0.005
-0.009
0.004
-0.003

32

Variables available in
the PSID

Stroke
Kidney Disease

Cancer
Neurological Condition
Lung Disease x Age
Asthma x Age
Severe Obesity x Age
Diabetes x Age
Hypertension x Age
Heart Disease x Age
Heart Attack x Age
Stroke x Age
Kidney Disease x Age

Cancer x Age
Neurological Condition x Age

Appendix C: Risk Factors by Subgroup and Differences in VI in Midlife by Two Dimensions
of Population Subgroup Membership

33

34

35

Appendix D: Calculation of VI among COVID-19 Hospitalized Patients
To calculate VI based on the average conditions of COVID-19 hospitalized patients overall
and by age group (18-49, 50-64, 65+), we use the prevalence of preexisting conditions of hospitalized patients reported in Garg et al. (20) and apply these prevalence rates to our calculation of
VI described in Equation (4) in the text. We match each condition with its corresponding condition
in DeCaprio et al. (23) as shown in Appendix Table D-1. For the two demographic factors in
DeCaprio et al. (23), age and gender, we apply the median age overall and in each age group from
the PSID and the percent of all hospitalized patients who are male (54%) from Garg et al. (20) to
each age group. There are several preexisting conditions in Garg et al. (20) that are not in the
DeCaprio et al. model and we do not include these in our calculations of VI.
Garg et al. (20) on preexisting conditions was only from March 2020 and for 178 hospitalized patients (12% of hospitalized adults), as these data require time-consuming abstractions from
hospital medical charts. Though the sample in Garg et al. (20) is small, it has the advantage that
preexisting conditions are reported overall and by age group. The incidence of preexisting health
conditions for adults is very similar to that data reported for the week ending June 6, 2020, although
June data are not reported by age (21).

36

Appendix Table D-1. Correspondence between Garg et al. (2020) and DeCaprio et
al. (2020)
Underlying Conditions Garg et al.
Corresponding Condition DeCaprio et al.
(2020)
(2020)
Hypertension
Hypertension
Obesity (BMI>=30)
Severe Obesity (BMI>=40)
Chronic metabolic disease
No exact match (excluded)
Â Â Â Diabetes mellitus
Diabetes
Chronic lung disease
Â Â Â Asthma
Asthma
Chronic obstructive pulmonary disease
Â Â Â Chronic obstructive pulmonary
(COPD) or emphysema, cystic fibrosis, or
disease
chronic bronchitis
Cardiovascular disease (not
hypertension)
Â Â Â Coronary artery disease
Â Â Â Congestive heart failure
Neurologic disease
Renal disease
Immunosuppressive condition
Gastrointestinal/Liver disease
Blood disorder
Rheumatologic/Autoimmune disease

Rheumatic and other heart disease
Congestive heart failure
Stroke
Chronic kidney disease
No exact match (excluded)
Liver disease
No exact match (excluded)

No exact match (excluded)
Notes: Pregnancy is excluded because we do not use it in the PSID estimation.
Garg et al. (2020) reports that 30% of obsese patients are severely obese and we
apply the percentage uniformly across age groups. We treat all reports of chronic
lung disease that are not asthma as being included in COPD, emphysema, cystic
fibrosis, or chronic bronchitis. We treat all reports of cardiovascular disease (not
hypertension) that are not congestive heart disease as coronary artery disease.
We have tested using applying the coefficients for neurocognitive conditions
instead of stroke as the corresponding condition for neurologic disease and the
results are unchanged. We have also tested using sickle cell/HIV/transplant in
DeCaprio et al. (2020) as a match for immunosuppresive conditions in Garg et al.
(2020). Again the results are very similar.

37

